118 related articles for article (PubMed ID: 38403662)
21. Acute Kidney Injury in Patients Receiving Systemic Treatment for Cancer: A Population-Based Cohort Study.
Kitchlu A; McArthur E; Amir E; Booth CM; Sutradhar R; Majeed H; Nash DM; Silver SA; Garg AX; Chan CT; Kim SJ; Wald R
J Natl Cancer Inst; 2019 Jul; 111(7):727-736. PubMed ID: 30423160
[TBL] [Abstract][Full Text] [Related]
22. Association Between Proton Pump Inhibitor Exposure and Acute Kidney Injury After Cardiac Surgery.
Koh HB; Joo YS; Kim HW; Jo W; Chan Kang S; Jhee JH; Han M; Lee M; Han SH; Yoo TH; Kang SW; Park JT
Mayo Clin Proc; 2023 Feb; 98(2):266-277. PubMed ID: 36737115
[TBL] [Abstract][Full Text] [Related]
23. Use of Proton Pump Inhibitors and the Risk of Acute Kidney Injury Among Patients with Rheumatoid Arthritis: Cohort Study.
Svanström H; Lund M; Melbye M; Pasternak B
Drug Saf; 2018 Aug; 41(8):817-826. PubMed ID: 29603109
[TBL] [Abstract][Full Text] [Related]
24. Risk of acute kidney injury following community prescription of antibiotics: self-controlled case series.
Rennie TJW; De Souza N; Donnan PT; Marwick CA; Davey P; Dreischulte T; Bell S
Nephrol Dial Transplant; 2019 Nov; 34(11):1910-1916. PubMed ID: 29961876
[TBL] [Abstract][Full Text] [Related]
25. A comparison of efficacy and safety of potassium-competitive acid blocker and proton pump inhibitor in gastric acid-related diseases: A systematic review and meta-analysis.
Simadibrata DM; Syam AF; Lee YY
J Gastroenterol Hepatol; 2022 Dec; 37(12):2217-2228. PubMed ID: 36181401
[TBL] [Abstract][Full Text] [Related]
26. Risk factors of immune checkpoint inhibitor-associated acute kidney injury: evidence from clinical studies and FDA pharmacovigilance database.
Chen P; Zhu J; Xu Y; Huang Q; Su J; Gao Z; Feng M
BMC Nephrol; 2023 Apr; 24(1):107. PubMed ID: 37087434
[TBL] [Abstract][Full Text] [Related]
27. Long-term continuous use of proton-pump inhibitors is associated with renal function decline in patients without acute kidney injury.
Hatakeyama Y; Horino T; Matsumoto T; Terada Y; Okuhara Y
Clin Exp Nephrol; 2021 Oct; 25(10):1087-1092. PubMed ID: 34089392
[TBL] [Abstract][Full Text] [Related]
28. Remdesivir use and risks of acute kidney injury and acute liver injury among patients hospitalised with COVID-19: a self-controlled case series study.
Wong CKH; Au ICH; Cheng WY; Man KKC; Lau KTK; Mak LY; Lui SL; Chung MSH; Xiong X; Lau EHY; Cowling BJ
Aliment Pharmacol Ther; 2022 Jul; 56(1):121-130. PubMed ID: 35318694
[TBL] [Abstract][Full Text] [Related]
29. Combination therapy with immune check point inhibitors and acute kidney injury.
Valentin A; Møller AKH; Palshof JA; Broberg B; Gravesen E; Svane IM; Hansen D
Acta Oncol; 2023 Feb; 62(2):121-125. PubMed ID: 36755491
[TBL] [Abstract][Full Text] [Related]
30. Association between proton pump inhibitor use and risk of pneumonia in children: nationwide self-controlled case series study in Sweden.
Wang YH; Svanström H; Wintzell V; Ludvigsson JF; Pasternak B
BMJ Open; 2022 Apr; 12(4):e060771. PubMed ID: 35450917
[TBL] [Abstract][Full Text] [Related]
31. Using proton pump inhibitors correlates with an increased risk of chronic kidney disease: a nationwide database-derived case-controlled study.
Hung SC; Liao KF; Hung HC; Lin CL; Lai SW; Lee PC; Hung SR
Fam Pract; 2018 Mar; 35(2):166-171. PubMed ID: 29045621
[TBL] [Abstract][Full Text] [Related]
32. Proton pump inhibitors and acute kidney injury: a nested case-control study.
Klepser DG; Collier DS; Cochran GL
BMC Nephrol; 2013 Jul; 14():150. PubMed ID: 23865955
[TBL] [Abstract][Full Text] [Related]
33. Is there overuse of proton pump inhibitors in B-cell non-Hodgkin lymphomas? A cohort study based on the French health insurance database in the Midi-Pyrénées region.
Conte C; Bourrel R; Despas F; Lapeyre-Mestre M
Fundam Clin Pharmacol; 2019 Jun; 33(3):327-338. PubMed ID: 30625254
[TBL] [Abstract][Full Text] [Related]
34. Proton pump inhibitors and the risk of hospital-acquired acute kidney injury in children.
Li Y; Xiong M; Yang M; Wang L; Nie S; Liu D; Pi M; Zhang A; Mao J; Liu HP; Xia H; Xu H; Liu Z; Feng S; Zhou W; Liu X; Yang Y; Tao Y; Feng Y; Chen C; Wang M; Zha Y; Feng JH; Li Q; Ge S; Chen J; He Y; Teng S; Hao C; Liu BC; Tang Y; He W; Hou FF; Xu X
Ann Transl Med; 2020 Nov; 8(21):1438. PubMed ID: 33313183
[TBL] [Abstract][Full Text] [Related]
35. Adverse effects of proton pump inhibitors (PPIs) on the renal system using data mining algorithms (DMAs).
Jain D; Sharma G; Kumar A
Expert Opin Drug Saf; 2023; 22(8):741-752. PubMed ID: 36888736
[TBL] [Abstract][Full Text] [Related]
36. A Study on the Status of Proton Pump Inhibitor Prescriptions Using Diagnosis Procedure Combination Data in Japan.
Sakata Y; Tsuruoka N; Takedomi H; Akutagawa T; Shimoda R; Esaki M; Fujimoto K
Digestion; 2020; 101(3):308-315. PubMed ID: 30840949
[TBL] [Abstract][Full Text] [Related]
37. Association Between Proton Pump Inhibitor Use and Risk of Progression of Chronic Kidney Disease.
Klatte DCF; Gasparini A; Xu H; de Deco P; Trevisan M; Johansson ALV; Wettermark B; Ärnlöv J; Janmaat CJ; Lindholm B; Dekker FW; Coresh J; Grams ME; Carrero JJ
Gastroenterology; 2017 Sep; 153(3):702-710. PubMed ID: 28583827
[TBL] [Abstract][Full Text] [Related]
38. Adverse outcomes of proton pump inhibitors in patients with chronic kidney disease: The CKD-REIN cohort study.
Liabeuf S; Lambert O; Metzger M; Hamroun A; Laville M; Laville SM; Frimat L; Pecoits-Filho R; Fouque D; Massy ZA; Jacquelinet C; Stengel B;
Br J Clin Pharmacol; 2021 Jul; 87(7):2967-2976. PubMed ID: 33368448
[TBL] [Abstract][Full Text] [Related]
39. No Increase in Risk of Acute Myocardial Infarction in Privately Insured Adults Prescribed Proton Pump Inhibitors vs Histamine-2 Receptor Antagonists (2002-2014).
Landi SN; Sandler RS; Pate V; Lund JL
Gastroenterology; 2018 Mar; 154(4):861-873.e6. PubMed ID: 29122546
[TBL] [Abstract][Full Text] [Related]
40. Proton Pump Inhibitor Use Is Associated with an Increased Frequency of New or Worsening Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Creation.
Lewis DS; Lee TH; Konanur M; Ziegler C; Hall MD; Pabon-Ramos WM; Suhocki PV; Smith TP; Kim CY; Choi SS; Ronald J
J Vasc Interv Radiol; 2019 Feb; 30(2):163-169. PubMed ID: 30638914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
